Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries

Menopause

Volumn 14, Issue 2, 2007, Pages 251-260

  Miller, Andrew P ^a,c   Xing, Dongqi ^a   Feng, Wenguang ^a   Fintel, Marion ^b   Chen, Yiu Fai ^a   Oparil, Suzanne ^a  

^a University of Alabama at Birmingham   (United States)

^b TALLADEGA COLLEGE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aging; Hormones; Inflammation; Restenosis; Women

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY INJURY; ARTICLE; CAROTID ARTERY; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; INTIMA; LEUKOCYTE; MACROPHAGE; MONOCYTE; MORPHOMETRICS; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT;

AGING; ANIMALS; CAROTID ARTERY INJURIES; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; INFLAMMATION MEDIATORS; LEUKOCYTES; OVARIECTOMY; RATS;

EID: 34247565156     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000235366.39726.f6     Document Type: Article

References (33)

1. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association, 2005.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
3. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941.
4. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995;273:199-208.
5. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
6. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619.
7. Miller AP, Chen YF, Xing D, Feng W, Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 2003;42:657-663.
8. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-365.
9. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534.
10. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996;93:577-584.
11. Levine RL, Chen SJ, Durand J, Chen YF, Oparil S. Medroxy-progesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation 1996;94:2221-2227.
12. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 1997;95:1301-1307.
13. Bakir S, Mori T, Durand J, Chen YF, Thompson JA, Oparil S. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 2000;101:2342-2344.
14. Mori T, Durand J, Chen Y, Thompson JA, Bakir S, Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid arteries. Am J Cardiol 2000;85:1276-1279.
15. Xing D, Miller A, Novak L, Rocha R, Chen YF, Oparil S. Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury. Circulation 2004;109:234-241.
16. Miller AP, Feng W, Xing D, et al. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004;110:1664-1669.
17. Karas RH. Animal models of the cardiovascular effects of exogenous hormones. Am J Cardiol 2002;90(Suppl):22F-25F.
18. Lu JKH. Changes in ovarian function and gonadotropin and prolactin secretion in ageing female rats. In: Meites J, ed. Neuroendocrinology of Aging. New York, NY: Plenum, 1983:103-122.
19. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Bethesda, MD: National Institutes of Health, 1996. NIH publication no. 85-23.
20. Oparil S, Chen SJ, Chen YF, Durand JN, Allen L, Thompson JA. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res 1999;44:608-614.
21. Tai JT, Brooks EE, Liang S, et al. Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model. Arterioscler Thromb Vasc Biol 2000;20:2184-2191.
22. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atherosclerosis by estrogen in cholesterol-fed chicks. Circulation 1952;6:276-280.
23. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci U S A 1982;79:3863-3866.
24. Hariri RJ, Hajjar DP, Coletti D, Alonso DR, Weksler ME, Rabellino E. Aging and atherosclerosis: cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol 1988;131:132-136.
25. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med 1988;167:163-174.
26. Urano J, Shirai K, Watanabe H, Miyashita Y, Hashiguchi S. Vascular smooth muscle cell outgrowth, proliferation, and apoptosis in young and old rats. Atherosclerosis 1999;146:101-105.
27. Torella D, Leosco D, Indolfi C, et al. Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol 2004;287:H2850-H2860.
28. Wynne FL, Payne JA, Cain AE, Reckelhoff JF, Khalil RA. Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats. Hypertension 2004;43:405-412.
29. Geraldes P, Sirois MG, Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 2003:399-405.
30. Pare G, Krust A, Karas RH, et al. Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 2002;90:1087-1092.
31. Losordo DW, Kearney M, Kim EA, Jekanowsky J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501-1510.
32. Leclercq G. Molecular forms of the estrogen receptor in breast cancer. J Steroid Biochem Mol Biol 2002;80:259-272.
33. Humphries KH, Westendorp IC, Bots ML, et al. Parity and carotid artery atherosclerosis in elderly women: the Rotterdam Study. Stroke 2001;32:2259-2264.